NCT07528118

Brief Summary

It is hypothesized that there is a difference between intravenously administered aminophylline with intravenous acetaminophen and intravenously administered aminophylline with dexamethasone for prevention of and reducing severity of PDPH.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for phase_2

Timeline
Completed

Started Aug 2023

Shorter than P25 for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2023

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 2, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 8, 2024

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

February 24, 2026

Completed
2 months until next milestone

First Posted

Study publicly available on registry

April 14, 2026

Completed
Last Updated

April 14, 2026

Status Verified

April 1, 2026

Enrollment Period

10 months

First QC Date

February 24, 2026

Last Update Submit

April 9, 2026

Conditions

Keywords

PDPHAcetaminophenAminophyllineDexamethasone

Outcome Measures

Primary Outcomes (1)

  • The primary outcome of the study is to see effectiveness of intravenous aminophylline in combination with dexamethasone and acetaminophen in terms of reducing incidence of PDPH in surgical patients with history of PDPH.

    Reduced Incidence of PDPH

    3 days

Secondary Outcomes (1)

  • Prophylactic administration of Aminophylline with Acetaminophen and Aminophylline with Dexamethasone on post-dural puncture headache prevention after spinal anesthesia in terms of reduced severity of PDPH by VAS scores.

    3 days

Other Outcomes (1)

  • *Reduced need for Rescue analgesia and *Reduced associated symptoms of PDPH after prophylactic administration of Aminophylline with Acetaminophen and Aminophylline with Dexamethasone.

    3 days

Study Arms (2)

Acetaminophen+Aminophylline (n=25)

EXPERIMENTAL

This group will receive Inj. Aminophylline 100mg as slow IV. Infusion over 30 minutes followed by inj. Acetaminophen 1000mg in 100 ml Normal saline solution as slow infusion.

Drug: Inj Aminophylline 100mg with Inj Acetaminophen 1000mg in 100ml Normal Saline

Aminophylline+Dexamethasone (n=25)

EXPERIMENTAL

This group will receive Inj. Aminophylline 100mg as slow IV infusion over 30minutes followed by 0.1mg/kg dexamethasone in 100ml Normal saline IV infusion.

Drug: Inj Aminophylline 100mg , with 0.1mg/kg Dexamethasone in 100ml Normal Saline

Interventions

This group will receive Inj. Aminophylline 100mg as slow IV. Infusion over 30 minutes followed by inj. Acetaminophen 1000mg in 100 ml Normal saline solution as slow infusion.

Also known as: Aminophylline, Acetaminophen
Acetaminophen+Aminophylline (n=25)

This group will receive Inj. Aminophylline 100mg as slow IV infusion over 30minutes followed by 0.1mg/kg dexamethasone in 100ml Normal saline IV infusion.

Also known as: Aminophylline, Dexamethasone
Aminophylline+Dexamethasone (n=25)

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients from 18-40 years.
  • Elective surgery under spinal anesthesia
  • Those patients having history of PDPH
  • BMI≤ 35kg/m2
  • American Society of Anesthesiologist (ASA) Physical Status I and II

You may not qualify if:

  • History of known allergy or hypersensitivity against study drug
  • Emergency surgery
  • Obstetric patient
  • Failed spinal
  • Multiple attempts of spinal
  • Contraindication to Spinal Anesthesia
  • Chronic disease patients already taking opioids or NSAIDs
  • History of migraine or other headaches
  • Partially effective spinal anesthesia
  • Abnormal liver or kidney function, cardiovascular system diseases, respiratory system diseases and diseases of the nervous system
  • Intraoperative blood loss \>1000ml
  • Intraoperative hemodynamic instability

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dr.Faisal Masood Teaching Hospital, Sargodha

Sargodha, Punjab Province, 40100, Pakistan

Location

Related Publications (1)

  • Jabalameli, M., Hashemi, S.T., Asadpoor, S., 2019. The efficacy of prophylactic intravenous aminophylline, paracetamol or aminophylline and paracetamol in prevention of post spinal headache in lower extremity surgeries compared to the control group. Tehran Univ. Medical J., 77(5), pp.294-300.

    BACKGROUND

Related Links

MeSH Terms

Conditions

Post-Dural Puncture Headache

Interventions

Saline SolutionAminophyllineAcetaminophenDexamethasone

Condition Hierarchy (Ancestors)

Headache Disorders, SecondaryHeadache DisordersBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

Crystalloid SolutionsIsotonic SolutionsSolutionsPharmaceutical PreparationsEthylenediaminesDiaminesPolyaminesAminesOrganic ChemicalsTheophyllineXanthinesPurinonesPurinesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic CompoundsDrug CombinationsAcetanilidesAnilidesAmidesAniline CompoundsPregnadienetriolsPregnadienesPregnanesSteroidsFused-Ring CompoundsPolycyclic CompoundsSteroids, Fluorinated

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: After approval of synopsis and approval from Institutional Ethical Review Board (IERB), 50 patients undergoing elective lower abdominopelvic and lower limb surgeries as per inclusion criteria in this study will be enrolled in this study.Two equal groups will be constituted. Informed consent will be taken from all patients after explaining the whole procedure, its merits, demerits, and alternate treatment options. Group A1 (n=25) will receive Inj. Aminophylline 100mg as slow IV. Infusion over 30 minutes followed by inj. Acetaminophen 1000mg in 100 ml Normal saline solution as slow infusion. Group A2 (n=25) will receive Inj. Aminophylline 100mg as slow IV infusion over 30minutes followed by 0.1mg/kg dexamethasone in 100ml Normal saline IV infusion.Drugs will be given in infusion form at the end of the procedure and once daily for 3 days. Coded Drug infusions will be administered by an anesthetist blinded to study groups at the end of the procedure in operation theatre and once daily
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 24, 2026

First Posted

April 14, 2026

Study Start

August 1, 2023

Primary Completion

June 2, 2024

Study Completion

July 8, 2024

Last Updated

April 14, 2026

Record last verified: 2026-04

Locations